NASDAQ:STML - Stemline Therapeutics Earnings Date, Estimates & History Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Stemline Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $14.17 +0.11 (+0.78 %) (As of 06/16/2019 04:00 PM ET) Add Compare Today's Range$13.85Now: $14.17▼$14.4450-Day Range$13.13MA: $14.60▼$16.1052-Week Range$7.82Now: $14.17▼$18.10Volume317,986 shsAverage Volume351,604 shsMarket Capitalization$619.09 millionP/E RatioN/ADividend YieldN/ABeta1.25 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Earnings Stemline Therapeutics (NASDAQ:STML) Earnings History and Estimates ChartStemline Therapeutics (NASDAQ:STML) Earnings Estimates2019 EPS Consensus Estimate: ($1.85)2020 EPS Consensus Estimate: ($0.26)QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20192($0.61)($0.50)($0.56)Q2 20192($0.52)($0.45)($0.49)Q3 20192($0.44)($0.40)($0.42)Q4 20192($0.42)($0.35)($0.39)Q1 20201($0.30)($0.30)($0.30)Q2 20201($0.14)($0.14)($0.14)Q3 20201$0.01$0.01$0.01Q4 20201$0.17$0.17$0.17Stemline Therapeutics (NASDAQ STML) Earnings History by QuarterDateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails8/8/2019(Estimated) 5/10/20193/31/2019($0.67)($0.73)($0.73)$2.61 million$5.05 millionViewListen3/15/2019Q4 2018($0.72)($0.92)($0.92)ViewN/A11/8/2018Q3($0.6740)($0.73)($0.73)ViewN/A8/9/2018Q2 2018($0.64)($0.66)($0.66)$0.50 millionViewN/A5/9/2018Q1 2018($0.7080)($0.69)($0.69)ViewN/A3/16/2018Q4 2017($0.67)($0.93)($0.93)ViewN/A11/9/2017Q3 2017($0.57)($0.68)($0.68)$0.30 million$0.30 millionViewN/A8/8/2017Q2 2017($0.48)($0.66)($0.66)$0.30 million$0.30 millionViewN/A5/10/2017Q1 2017($0.45)($0.67)($0.67)$0.30 million$0.30 millionViewN/A3/16/2017Q4 2016($0.55)($0.56)($0.56)$0.25 million$0.30 millionViewN/A11/8/2016Q3 2016($0.53)($0.56)($0.56)$0.15 million$0.30 millionViewN/A8/4/2016Q2 2016($0.54)($0.52)($0.52)$0.17 million$0.24 millionViewN/A5/9/2016Q1 2016($0.59)($0.51)($0.51)$121.43 million$205.65 millionViewN/A3/14/2016Q4 2015($0.57)($0.58)($0.58)$0.15 million$0.21 millionViewN/A11/6/2015Q3 2015($0.59)($0.53)($0.53)$0.10 million$0.21 millionViewN/A8/10/2015Q2 2015($0.45)($0.58)($0.58)$0.10 million$0.12 millionViewN/A5/11/2015Q1 2015($0.45)($0.46)($0.46)$0.09 million$0.12 millionViewN/A3/13/2015Q4 2014($0.59)($0.53)($0.53)$0.07 million$0.12 millionViewN/A11/12/2014Q3 2014($0.58)($0.53)($0.53)$0.07 million$0.07 millionViewN/A8/14/2014Q2 2014($0.71)($0.47)($0.47)$0.07 million$0.07 millionViewN/A5/15/2014Q1 2014($0.72)($0.70)($0.70)$0.0710 million$0.0710 millionViewN/A11/12/2013Q3 2013($0.45)($0.45)ViewN/A5/14/2013Q1 2013($0.90)($0.90)ViewN/A4/1/2013Q4 2012($0.38)($0.38)ViewN/A(Earnings results data provided by Zacks Investment Research) This page was last updated on 6/16/2019 by MarketBeat.com StaffFeatured Article: What is the Beige Book?
